SCHEMBL25384673

SCHEMBL25384673

Cc1cnc(COc2ccc(N)cc2C)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 6/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MRGPRX4 Q96LA9 2/20 0.35
KDM4E B2RXH2 4/20 0.34
MAPT P10636 4/20 0.34
GAA P10253 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
CASP1 P29466 1/20 0.34
HTT P42858 1/20 0.34
CASP7 P55210 1/20 0.34
ATM Q13315 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30354875 1.00 SYK (0.38) SYKL3MBTL1ALDH1A1HDAC1HDAC6
SCHEMBL25382070 0.85 GAA (0.53) SYKALDH1A1KDM4EMAPTGAA
SCHEMBL30354812 0.85 GAA (0.53) SYKALDH1A1KDM4EMAPTGAA
SCHEMBL23538130 0.85 SYK (0.45) SYKALDH1A1HDAC1HDAC6MRGPRX4
SCHEMBL30354916 0.81 SYK (0.43) SYKL3MBTL1ALDH1A1MRGPRX4KDM4E
SCHEMBL4001505 0.78 NOS1 (0.50) SYKL3MBTL1MAPTNPC1RAB9A
SCHEMBL6068795 0.78 MRGPRX4 (0.48) SYKALDH1A1MRGPRX4KDM4ETP53
SCHEMBL30354879 0.78 TDP1 (0.46) L3MBTL1ALDH1A1MAPTGAAKMT2A
SCHEMBL29151249 0.76 TDP1 (0.44) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL30354789 0.76 TDP1 (0.44) ALDH1A1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278965-A1 NOVEL CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS COMPRISING 2 OR MORE ARYL OR HETEROARYL CONNECTED VIA LINKER AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278965-A1 NOVEL CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS COMPRISING 2 OR MORE ARYL OR HETEROARYL CONNECTED VIA LINKER AND USE THEREOF AADAC, CBR3, MTCL3 SYK 1963/4885L3MBTL1 2549/4885ALDH1A1 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.